Arete Wealth Advisors, LLC Opti Nose, Inc. Transaction History

Arete Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.82 - $1.44 $8,200 - $14,400	10,000 New	10,000 $10,000
Q1 2023 May 01, 2023	BUY	$1.63 - $2.02 $16,299 - $20,200	10,000 New	10,000 $19,000
Q3 2022 Nov 07, 2022	BUY	$3.43 - $4.01 $41,160 - $48,120	12,000 New	12,000 $44,000
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.82 $21,120 - $45,840	-12,000 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$1.55 - $3.1 $18,600 - $37,200	12,000 New	12,000 $19,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $31.6M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Arete Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Arete Wealth Advisors, LLC with notifications on news.